Category Archives: HIV care & treatment

Injection-free technique could solve global HIV vaccine challenge

posts_vaccine_0

via Positively Aware, Chicago Scientists at King’s College, London, have demonstrated the ability to deliver a dried live vaccine to the skin without a traditional injection, and shown for the first time that this technique is powerful enough to enable specialized immune cells in the skin to…Read More

Smoking cuts lifespan of HIV-positive people by 15 years

posts_smoking_0

A large observational study reported in December 2012 that HIV-positive people have a significantly higher risk for death and shorter lifespans than their HIV-negative counterparts. The study showed that even with well-controlled virus, HIV-positive smokers lose far more years to smoking than they do to HIV…Read More

New 800mg Prezista tablets reduce daily pill count

Prezista

The FDA approved a new 800mg tablet of Prezista (darunavir) on November 9, 2012. This new formulation will allow people to take one pill daily instead of two 400mg pills of the drug daily, which is the current standard of care. People new to treatment as…Read More

New integrase inhibitor dolutegravir suppresses HIV as well as raltegravir

integrase inhibitor dolutegravir

Results from the SPRING-2 study were reported in the January 8, 2013 advanced edition of The Lancet. The 48-week, double-blind study followed people new to treatment who took either the experimental integrase inhibitor dolutegravir or the approved integrase inhibitor raltegravir (Isentress). A total of 822 people…Read More

New medication called crofelemer now available for HIV-related diarrhea

Fulyzaq (crofelemer)

At the end of December 2012, the FDA approved the first medication (crofelemer/Fulyzaq) to relieve the symptoms of diarrhea in people who are taking HIV medications. Many people who take HIV meds experience diarrhea, which can lead to some stopping or switching their meds. The approval…Read More

Influential US Task Force now recommends HIV testing for broader portion of Americans

HIV testing

New draft recommendations from the US Preventive Services Task Force (USPSTF) were issued recently to routinely test all adolescents and adults between 15 and 65 years of age for HIV infection, as well as others who fall outside of this age range if they are at…Read More

Can surveillance data improve HIV care?

Surveillance

On November 5 and 6, Project Inform convened a meeting in San Francisco, bringing together community advocates and public health professionals to answer a complex question: When and how should surveillance data be used to help find those who aren’t linked to HIV medical care and…Read More